ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations and ...
ProPhase Labs is a diversified biotech company with profitable existing product lines and plans for expansion. The company's subsidiary, Nebula Genomics, offers whole genome sequencing and plans to ...
GARDEN CITY, NY, May 20, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today reported its ...
There are no upcoming dividends for ProPhase Labs.The last dividend paid last dividend payout June 3, 2022 and was $0.30. ProPhase Labs has no upcoming dividends reported. The last reported dividend ...
UNIONDALE, NY, Feb. 02, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET ...
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript May 20, 2025 ProPhase Labs, Inc. beats earnings expectations. Reported EPS is $-0.14, expectations were $-0.18. Noella ...
Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company’s Balance Sheet. UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc.
ProPhase Labs (PRPH) explores sale/partnership for BE-Smart esophageal cancer test and updates Crown Medical COVID claim recoveries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results